Hydrolyzed Starch 3D Printing Materials for Controlled Release

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The pharmaceutical industry faces limitations in 3D printing technologies due to a lack of environmentally friendly, edible, and printer-friendly materials for producing solid dosage forms with desired mechanical, biological, and pharmacokinetic properties, particularly for achieving controlled release profiles and enhanced water-solubility of active ingredients.

Innovation Solution

The use of hydrolyzed and functionalized starch compounds, which are derived from renewable resources, exhibiting improved mechanical properties and solubility, allowing for the creation of printable materials suitable for various 3D printing technologies such as FDM and PAM, enabling the production of dosage forms with instant or modified release profiles and enhanced water-solubility of active ingredients.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional synthetic polymers (PVP, PVA, PLA) are used for 3D printing pharmaceutical dosage forms, then printer-friendly properties and mechanical strength are achieved, but environmental friendliness and edibility are compromised

Engineering Contradiction:
Improvemechanical strengthVSAvoidenvironmental friendliness
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent modifies starch parameters through hydrolysis (controlling DE value) and functionalization (adding specific chemical groups) to transform it from an unsuitable natural polymer into a printer-friendly material that maintains mechanical strength while being environmentally friendly and edible

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates composite printable materials by combining hydrolyzed and functionalized starch with other pharmaceutical excipients, achieving both environmental friendliness and the mechanical properties necessary for 3D printing dosage forms

Inventive Principle:
Principle #40Composite materials

2Object-affected harmful factors

If natural biopolymers are used for 3D printing, then environmental friendliness and edibility are improved, but printer-friendly properties and mechanical strength deteriorate

Engineering Contradiction:
Improveenvironmental friendlinessVSAvoidmechanical strength
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The patent applies parameter changes by controlling the degree of hydrolysis (DE value between 3-20) and introducing specific functional groups to starch, transforming it from a weak natural polymer into a material with sufficient mechanical strength for 3D printing while retaining environmental benefits

Inventive Principle:
Principle #35Parameter changes

3Ease of manufacture

If standard compression methods are used for manufacturing dosage forms, then manufacturing simplicity is maintained, but water-solubility of active ingredients is limited

Engineering Contradiction:
Improvemanufacturing simplicityVSAvoidwater-solubility
Core Design Contradiction:
Ease of manufactureVSQuantity of substance

Solution Approach 1:

The patent uses hydrolyzed and functionalized starch as an intermediary material in 3D printing that actively enhances the water-solubility of active ingredients through its specific molecular structure and hydrophilic properties, achieving up to tenfold solubility enhancement

Inventive Principle:
Principle #24Intermediary (Mediator)

4Strength

If conventional 3D printing materials are used, then basic structural integrity is achieved, but controlled release profiles and pharmacokinetic performance are insufficient

Engineering Contradiction:
Improvestructural integrityVSAvoidcontrolled release profile
Core Design Contradiction:
StrengthVSDuration of action of moving object

Solution Approach 1:

The patent utilizes parameter changes in the starch structure (hydrolysis degree, functional groups) to control the erosion and dissolution rates of the printed dosage forms, enabling tailored controlled release profiles while maintaining structural integrity during printing

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent applies local quality by creating radial gradients of erosion or diffusion-controlling excipients within the printed dosage form, allowing different regions to have different release rates for optimized pharmacokinetic performance

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The hydrolyzed and functionalized starch compounds demonstrate improved printability and pharmacokinetic performance, achieving up to tenfold enhancement in water-solubility of active ingredients compared to standard compression methods, and allowing for the production of dosage forms with tailored release profiles, thereby addressing the limitations of existing materials in 3D printing technologies.

Implementation Method 1

The use of hydrolyzed and functionalized starch compounds, which are derived from renewable resources, exhibiting improved mechanical properties and solubility

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Data Source

PatentUS20240307311A1Starch based printable materials
Publication Date: 2024.09.19 ROQUETTE FRERES SA
  • US20240307311A1 patent drawing
  • US20240307311A1 patent drawing
  • US20240307311A1 patent drawing

AI summary

The instant invention relates to a printable material for 3D printing comprising a hydrolyzed and functionalized starch compound. It also relates to a process for 3D printing using the same. It also relates to products, in particular solid dosage forms, obtained thereof by 3D printing.